OCCIDENT

OCCIDENT is a venture capital firm in Munich investing its own capital in deep-tech spin-offs from scientific research, with a focus on life sciences, industrial technology, biotechnology, medical devices and pharmaceuticals. It backs startups from seed through later-stage rounds, has acted as a lead investor, and invests across Switzerland, Germany, Finland, Slovenia and Austria, making it relevant for technical founders seeking long-term venture backing.